Patents Assigned to LAM Therapeutics, Inc.
  • Patent number: 10206910
    Abstract: The present disclosure relates to methods for treating renal cancer with apilimod and related compositions and methods.
    Type: Grant
    Filed: November 6, 2015
    Date of Patent: February 19, 2019
    Assignee: LAM Therapeutics, Inc.
    Inventors: Neil Beeharry, Sophia Gayle, Sean Landrette, Paul Beckett, Chris Conrad, Tian Xu, Jonathan M. Rothberg, Henri Lichenstein
  • Patent number: 10179135
    Abstract: The present invention relates to methods for treating cancer with apilimod and related compositions and methods.
    Type: Grant
    Filed: January 23, 2015
    Date of Patent: January 15, 2019
    Assignee: LAM Therapeutics, Inc.
    Inventors: Henri Lichenstein, Jonathan M. Rothberg, Sophia Gayle, Neil Beeharry, Paul Beckett, Sean Landrette, Chris Conrad, Matt Dyer, Tian Xu
  • Publication number: 20180015098
    Abstract: The present invention relates to methods for treating Charcot-Marie-Tooth Disease (CMT) with apilimod and related compositions and methods.
    Type: Application
    Filed: February 2, 2016
    Publication date: January 18, 2018
    Applicant: LAM Therapeutics, Inc.
    Inventors: Henri LICHENSTEIN, Jonathan M. ROTHBERG
  • Publication number: 20170014341
    Abstract: The present invention relates to methods and compositions for anti-aging therapy and for the treatment and prophylaxis of age-related diseases and disorders in a human subject in need of such therapy or treatment, the methods comprising the pulmonary administration to the subject, preferably via inhalation, of composition comprising rapamycin, or a prodrug or derivative thereof.
    Type: Application
    Filed: April 6, 2015
    Publication date: January 19, 2017
    Applicant: LAM Therapeutics, Inc.
    Inventors: Thomas Armer, Lawrence S. Melvin, Jonathan M. Rothberg, Henri Lichenstein
  • Publication number: 20150197759
    Abstract: In some embodiments, aspects of the disclosure provide methods and compositions that are useful for modifying (e.g., mutating) one or more alleles of a genomic locus within a cell. In some embodiments, methods and compositions described herein involve producing a chimeric spliced RNA molecule that includes a transcribed exon spliced to a nuclease interacting RNA segment. In some embodiments, the chimeric spliced RNA guides a DNA modifying enzyme (e.g., a nuclease) to a genomic locus in a cell resulting in modification of the locus.
    Type: Application
    Filed: January 14, 2015
    Publication date: July 16, 2015
    Applicant: LAM Therapeutics, Inc.
    Inventors: Tian Xu, Jonathan M. Rothberg